Citations

Showing 10 of 108104 citations.

Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α -Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)
Chahine, Lana M. , Beach, Thomas G. , Seedorff, Nicholas , Caspell‐Garcia, Chelsea , Coffey, Christopher S. , Brumm, Michael C. , Linder, Carly, Mosovsky, Sherri, Riss, Holly, Ecklund, Dixie , Seibyl, John , Jennings, Danna , Arnedo, Vanessa , Riley, Lindsey , Dave, Kuldip D. , Mollenhauer, Brit , study, on behalf of the Systemic sSynuclein Sampling, Adler, Charles H. , Serrano, Geidy E. , Foroud, Tatiana , study, on behalf of the Systemic sSynuclein Sampling

Mayo Clinic

Journal of Parkinson’s Disease | September 21, 2018 | Volume: 8 | Issue: 4 | Pages: 517-527

10.3233/jpd-181434 | PMID 30248065 Get It

Background: α-synuclein is a lead Parkinson’s disease (PD) biomarker. There are conflicting reports regarding accuracy of α-synuclein in different tissues and biofluids as a PD biomarker, and the within-subject anatomical distribution of α-synuclein is not well described. The Systemic Synuclein Sampling Study (S4) aims to address these gaps in knowledge. The S4 is a multicenter, cross-sectional, observational study evaluating α-synuclein in multiple tissues and biofluids in PD and healthy controls (HC). Objective: To describe the baseline characteristics of the S4 cohort and safety and feasibility of this study. Methods: Participants underwent motor and non-motor clinical assessments, dopamine transporter SPECT, biofluid collection (cerebrospinal fluid, saliva, and blood), and tissue biopsies (skin, sigmoid colon, and submandibular gland). Biopsy adequacy was determined based on presence of adequate target tissue. Tissue sections were stained with the 5C12 monoclonal antibody against unmodified α-synuclein. All specimens were acquired and processed in a standardized manner. Adverse events were systematically recorded. Results: The final cohort consists of 82 participants (61 PD, 21 HC). In 68 subjects (83%), all types of specimens were obtained but only 50 (61%) of subjects had all specimens both collected and evaluable for α-synuclein. Mild adverse events were common, especially for submandibular gland biopsy, but only 1 severe adverse event occurred. Conclusion: Multicenter tissue and biofluid sampling for α-synuclein is feasible and generally safe. S4 will inform understanding of the concurrent distribution of α-synuclein pathology and biomarkers in biofluids and peripheral nervous system in PD.
Centers for Medicare & Medicaid Services’ decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence
Shishehbor, Mehdi H. , Misra, Sanjay , Schneider, Peter A. , Lookstein, R. , Kashyap, Vikram S. , Clair, Daniel G. , Katzen, Barry T. , Misra, Sanjay , White, Christopher J. , Beckman, Joshua A. , Jones, W. Schuyler , Rosenfield, Kenneth , Jaff, Michael R. , Kashyap, Vikram S

Mayo Clinic

Vascular Medicine | September 21, 2018 | Volume: 23 | Issue: 6 | Pages: 558-559

10.1177/1358863x18802969 | PMID 30238852 Get It

Correlation of Exhaled Nasal Nitric Oxide With Sinus Computed Tomography and Sinonasal Outcome Test Scores: A Cross-sectional Pilot Study
Oliver, Jeremie D. , Lim, Kaiser G. , O’Brien, Erin K. , Oliver, Jeremie D , O'Brien, Erin K , Lim, Kaiser G

Mayo Clinic

American Journal of Rhinology & Allergy | September 21, 2018 | Volume: 32 | Issue: 6 | Pages: 533-538

10.1177/1945892418801389 | PMID 30238790 Get It

Background Computed tomography (CT) of the paranasal sinuses is the diagnostic reference standard for chronic rhinosinusitis and related inflammatory sinus pathology. Nasal nitric oxide (nNO) levels have been investigated as a diagnostic tool in sinus disease because it decreases with sinus obstruction. Objective The primary aim of the study was to determine the correlation of passive (baseline) and dynamic (humming) nNO to CT findings of sinus inflammation and to sinonasal symptoms measured by the modified Sinonasal Outcome Test (26 items) (SNOT-26). Methods From June 2015 through January 2016, subjects had baseline and humming nNO levels measured with a chemiluminescence NO analyzer, and each subject underwent CT imaging and completed the SNOT-26 survey. CT images were scored using the Lund–Mackay (LM) system (LM scores >3 indicated sinus inflammation). Correlation was measured by linear and ordinal regression analysis that compared SNOT-26 scores, LM scores, and nNO measurements. Results Fourteen subjects were recruited. LM scores had a positive pairwise correlation with total SNOT-26 scores ( R 2 = .1457; correlation = .3817) and nasal-specific SNOT-26 scores ( R 2 = .4036; correlation = .6353). Baseline nasal nNO scores had a negative pairwise correlation with LM scores ( R 2 = .1580; correlation = −.3582), total SNOT-26 scores ( R 2 = .1515; correlation = −.3893), and nasal-specific SNOT-26 scores ( R 2 = .0805; correlation = −.4343). Although baseline nNO levels correlated with LM and SNOT-26 scores, humming nNO levels did not show a similar correlation. Conclusion Baseline passive nNO may be a useful and inexpensive point-of-care screening test for sinonasal opacification.
Diaphragm muscle function following midcervical contusion injury in rats
Khurram, Obaid U. , Fogarty, Matthew J. , Rana, Sabhya , Vang, Pangdra , Sieck, Gary C. , Mantilla, Carlos B. , Khurram, Obaid U , Rana, S , Fogarty, Matthew J

Mayo Clinic

Journal of Applied Physiology | September 21, 2018 | Volume: 126 | Issue: 1 | Pages: 221-230

10.1152/japplphysiol.00481.2018 | PMID 30236045 Get It

Midcervical spinal cord contusion injury results in tissue damage, disruption of spinal pathways, and motor neuron loss. Unilateral C4 contusion results in loss of 40%–50% of phrenic motor neurons ipsilateral to the injury (~25% of the total phrenic motor neuron pool). Over time after unilateral C4 contusion injury, diaphragm muscle (DIAm) electromyogram activity increases both contralateral and ipsilateral to the side of injury in rats, suggesting compensation because of increased activation of the surviving motor neurons. However, the impact of contusion injury on DIAm force generation is less clear. Transdiaphragmatic pressure (Pdi) was measured across motor behaviors over time after unilateral C4 contusion injury in adult male Sprague-Dawley rats. Maximum Pdi (Pdimax) was elicited by bilateral phrenic nerve stimulation at 7 days postinjury. We hypothesized that Pdimaxis reduced following unilateral C4 contusion injury, whereas ventilatory behaviors of the DIAm are unimpaired. In support of our hypothesis, Pdimaxwas reduced by ~25% after unilateral C4 contusion, consistent with the extent of phrenic motor neuron loss following contusion injury. One day after contusion injury, the Pdi amplitude during airway occlusion was reduced from ~30 to ~20 cmH2O, but this reduction was completely reversed by 7 days postinjury. Ventilatory behaviors (~10 cmH2O), DIAm-specific force, and muscle fiber cross-sectional area did not differ between the laminectomy and contusion groups. These results indicate that the large reserve capacity for DIAm force generation allows for higher-force motor behaviors to be accomplished despite motor neuron loss, likely reflecting changes in motor unit recruitment.NEW & NOTEWORTHY Respiratory muscles such as the diaphragm generate the pressures necessary to accomplish a variety of motor behaviors ranging from ventilation to near-maximal expulsive behaviors. However, the impact of contusion injury on diaphragm pressure generation across behaviors is not clear. The present study shows that contusion injury impairs maximal pressure generation while preserving the ability of the diaphragm to accomplish lower-force motor behaviors, likely reflecting changes in diaphragm motor unit recruitment.
Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing
Mills, John R. , Campion, Michael B., Vidal‐Folch, Noemi, Voss, Jesse S. , Halling, Kevin C. , Highsmith, W. Edward, Liu, Minetta C. , Kipp, Benjamin R. , Grebe, Stefan K. , Vidal-Folch, Noemi, Grebe, Stefan K G, Milosevic, Dragana

Mayo Clinic

Clinical Chemistry | September 20, 2018 | Volume: 64 | Issue: 12 | Pages: 1732-1742

10.1373/clinchem.2018.291278 | PMID 30237149 Get It

AbstractBACKGROUNDDroplet digital PCR (ddPCR) is an emerging technology for quantitative cell-free DNA oncology applications. However, assay performance criteria must be established in a standardized manner to harness this potential. We reasoned that standard protocols used in clinical chemistry assay validation should be able to fill this need.METHODSWe validated KRAS, EGFR, and BRAF quantitative ddPCR assays based on the Clinical Laboratory Improvement Act regulations for laboratory-developed tests in clinical chemistry and the matching Clinical and Laboratory Standards Institute guidelines. This included evaluation of limit of the blank (LOB), limit of detection (LOD), limit of quantification (LOQ), intraassay and interassay imprecision, analytical range, dilution linearity, accuracy (including comparison with orthogonal platforms), reference range study, interference, and stability studies.RESULTSFor the ddPCR assays, the LOB was 4 mutant copies, LODs were 12 to 22 copies, and LOQs were 35 to 64 copies. The upper limit of the dynamic range was 30000 copies, and dilutions were linear down to the LOQs with good accuracy of spike recovery of Horizon reference material. Method comparisons with next-generation sequencing and an alternative ddPCR platform showed complete qualitative agreement and quantitative concordance, with slopes of 0.73 to 0.97 and R2s of 0.83 to 0.99. No substantial interferences were discovered. Wild-type copy numbers in plasma ranged from 462 to 6169/mL in healthy individuals.CONCLUSIONSStandard clinical chemistry assay validation protocols can be applied to quantitative ddPCR assays. This should facilitate comparison of the performance of different assays and allow establishment of minimal significant change thresholds in monitoring applications.
Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?
Thanarajasingam, Gita , Nowakowski, Grzegorz S. , Thompson, Carrie A. , Maurer, Matthew J. , Habermann, Thomas M. , Bennani, N. Nora , Cerhan, James R. , Witzig, Thomas E.

Mayo Clinic

Nutrition and Cancer | September 20, 2018 | Volume: 70 | Issue: 7 | Pages: 1088-1090

10.1080/01635581.2018.1502328 | PMID 30235018 Get It

Weaponizing Hope: Sources of Hope, Unrealistic Optimism, and Denial
Michie, Marsha , Allyse, Megan , Stoll, Katie , Allyse, Megan A , Master, Zubin

Mayo Clinic

The American Journal of Bioethics | September 20, 2018 | Volume: 18 | Issue: 9 | Pages: 25-27

10.1080/15265161.2018.1498946 | PMID 30265599 Get It

Autoimmune epilepsy: findings on MRI and FDG-PET
Watson, Robert E. , Guerin, Julie, Carr, Carrie M. , Liebo, Greta B. , Kotsenas, Amy L. , Guérin, J.

Mayo Clinic

The British Journal of Radiology | September 20, 2018 | Volume: 92 | Issue: 1093 | Pages: No page available

10.1259/bjr.20170869 | PMID 30235015 Get It

Autoimmune epilepsy (AE) is becoming increasingly recognized as a potentially reversible cause of frequent or medically intractable seizures and cognitive deterioration. We describe various presentations of autoimmune encephalopathy which have specifically presented with seizure and describe reported imaging findings. This is organized as a review of the more common autoantibodies which can specifically precipitate seizure according to the intracellular or extracellular location of the targeted antigen. For each antibody, we illustrate their pathophysiology, characteristic clinical presentations with typical effective treatments and prognoses and imaging findings on MRI and PET/CT exams. Parenchymal involvement is variable with the limbic structures typically affected; however, non-limbic cortex, cerebellum, brainstem and basal ganglia can also be involved. In the acute setting, affected regions typically demonstrate T 2 hyperintensity with mild mass effect from edema and increased 18F-fludeoxyglucose uptake. Chronically involved parenchyma will often undergo atrophy and demonstrate decreased metabolism; mesial temporal sclerosis is often the end result when the limbic system is involved. Without treatment, long-term effects from AE range from ongoing cognitive dysfunction and refractory seizures to death. Familiarity with AE may prompt appropriate antibody screening, particularly in cases of refractory seizure disorders. Early investigation and proper management of AE cases may help to prevent parenchymal and neurologic deterioration in these patients.
Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis
Menghrajani, Kamal , Boonstra, Philip S. , Mercer, Jessica, Perkins, Cecelia , Gowin, Krisstina , Weber, Alissa A., Wang, Lixia , Talpaz, Moshe , Gowin, Krisstina L, Mesa, Ruben, Talpaz, Moshe , Mesa, Ruben A. , Gotlib, Jason , Singer, Jack W.

Mayo Clinic

Leukemia & Lymphoma | September 20, 2018 | Volume: 60 | Issue: 4 | Pages: 1036-1042

10.1080/10428194.2018.1509315 | PMID 30234400 Get It

Smoking and Risk of Microscopic Colitis: A Systematic Review and Meta-analysis
Jaruvongvanich, Veeravich , Poonsombudlert, Kittika , Ungprasert, Patompong

Mayo Clinic

Inflammatory Bowel Diseases | September 20, 2018 | Volume: 25 | Issue: 4 | Pages: 672-678

10.1093/ibd/izy296 | PMID 30869794 Get It